Healthcare provider profile · identity verified

Codey Lance Fontenot, M.D.

Internal Medicine · BATON ROUGE, LA · NPI 1568752277

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	450	121
Atorvastatin Calcium	Atorvastatin Calcium	440	128
Pantoprazole Sodium	Pantoprazole Sodium	277	79
Levothyroxine Sodium	Levothyroxine Sodium	243	65
Montelukast Sodium	Montelukast Sodium	219	113
Meloxicam	Meloxicam	182	65
Fluticasone Propionate	Fluticasone Propionate	174	83
Hydrochlorothiazide	Hydrochlorothiazide	172	51
Omeprazole	Omeprazole	168	48
Losartan Potassium	Losartan Potassium	165	50
Rosuvastatin Calcium	Rosuvastatin Calcium	165	47
Tamsulosin Hcl	Tamsulosin Hcl	156	45
Azelastine Hcl	Azelastine Hcl	137	84
Metformin Hcl Er	Metformin Hcl	136	36
Metformin Hcl	Metformin Hcl	134	32
Zolpidem Tartrate	Zolpidem Tartrate	126	22
Metoprolol Succinate	Metoprolol Succinate	121	33
Lisinopril	Lisinopril	120	39
Simvastatin	Simvastatin	114	29
Gabapentin	Gabapentin	110	41
Sertraline Hcl	Sertraline Hcl	106	25
Valsartan	Valsartan	106	28
Escitalopram Oxalate	Escitalopram Oxalate	98	29
Pravastatin Sodium	Pravastatin Sodium	95	30
Trazodone Hcl	Trazodone Hcl	86	27
Furosemide	Furosemide	83	27
Alprazolam	Alprazolam	82	23
Azithromycin	Azithromycin	82	66
Albuterol Sulfate Hfa	Albuterol Sulfate	81	30
Mounjaro	Tirzepatide	76	13
Celecoxib	Celecoxib	66	15
Potassium Chloride	Potassium Chloride	65	17
Allopurinol	Allopurinol	63	18
Mirtazapine	Mirtazapine	63	14
Tizanidine Hcl	Tizanidine Hcl	61	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	18
Ozempic	Semaglutide	59	13
Clonazepam	Clonazepam	57	13
Clopidogrel	Clopidogrel Bisulfate	54	17
Olmesartan Medoxomil	Olmesartan Medoxomil	53	16
Doxazosin Mesylate	Doxazosin Mesylate	52	14
Prednisone	Prednisone	51	40
Atenolol	Atenolol	47	suppressed
Fenofibrate	Fenofibrate	46	13
Carvedilol	Carvedilol	45	15
Metoprolol Tartrate	Metoprolol Tartrate	45	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	12
Bupropion Xl	Bupropion Hcl	40	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	14
Benazepril Hcl	Benazepril Hcl	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	12
Ondansetron Hcl	Ondansetron Hcl	38	suppressed
Pregabalin	Pregabalin	37	12
Jardiance	Empagliflozin	36	13
Synthroid	Levothyroxine Sodium	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	30
Ezetimibe	Ezetimibe	34	suppressed
Glipizide	Glipizide	34	suppressed
Cefdinir	Cefdinir	33	31
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	32	suppressed
Mupirocin	Mupirocin	31	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Methocarbamol	Methocarbamol	30	22
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	11
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Finasteride	Finasteride	25	suppressed
Fluconazole	Fluconazole	25	21
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Levofloxacin	Levofloxacin	25	20
Xarelto	Rivaroxaban	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	17
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	19
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	22
Bumetanide	Bumetanide	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	20
Dutasteride	Dutasteride	21	suppressed
Eliquis	Apixaban	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Chlorthalidone	Chlorthalidone	18	suppressed
Desloratadine	Desloratadine	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Topiramate	Topiramate	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Diazepam	Diazepam	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	12
Lactulose	Lactulose	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Methimazole	Methimazole	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Euthyrox	Levothyroxine Sodium	12	suppressed
Naproxen	Naproxen	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error